DeNovix Inc.
Market Development Manager
Andrew is currently the Market Development Manager with DeNovix Inc. having initially joined the Technical Advisory board in 2012.
Prior to DeNovix Inc., Andrew was European Clinical and Translation Medicine Manager with Affymetrix and previously held sales and management roles at Roche Diagnostics in the microarray and next generation sequencing markets.
A graduate of the University of Wales, Andrew is a Master of Research in Life Science and is based in the South of England.
The award-winning DS-11 Series Spectrophotometer / Fluorometer is unique in combining microvolume and cuvette UV-Vis, with Fluorescence in one instrument. This tech talk introduces and explains some of the key innovations from DeNovix that eliminate common problems with microvolume measurements. Expand to see more
The importance of fluorescence assays as part of a robust sample QC procedure is discussed in addition to the advantages of combining the sensitivity and specificity of fluorescence with the quantification and contamination detection of absorbance.